AdvisorNet Financial »

Context Therapeutics shares owned by AdvisorNet Financial

Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by AdvisorNet Financial from 13F filings

Historical chart of AdvisorNet Financial investment in Context Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Context Therapeutics held by AdvisorNet Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Context Therapeutics by AdvisorNet Financial

Quarter filed Position value Share count Share price at filing
2024-09-30 $392 200 1.96

More positions owned by AdvisorNet Financial

Spdr Portfolio S&p 500 Etf Etf (SPLG)
Tr Activebeta Us Large Cap Equity Etf Etf (GSLC)
Ishares S&p 500 Index Etf (IVV)
Microsoft Stock (MSFT)
Apple Stock (AAPL)
Dimensional International Core Equity 2 Etf Etf (DFIC)
Vanguard Total Stock Market Etf Etf (VTI)
Ishares Aggregate Bond Etf Etf (AGG)
Schwab Us Dividend Equity Etf Etf (SCHD)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Jpmorgan Ultra-short Income Etf Etf (JPST)
Nvidia Corporation Stock (NVDA)
Dimensional Us Core Equity Market Etf Etf (DFAU)
Ishares Dj Us Technology Etf (IYW)
Vanguard Growth Etf Etf (VUG)

View all positions for AdvisorNet Financial

Top funds holding Context Therapeutics

Deep Track Capital
Nextech Invest
Avidity Partners Management
Dr. Jeffrey R. Jay, M.D.
Blue Owl Capital Holdings
Vanguard Group
Blackstone Group
Nantahala Capital Management
Franklin Resources
Alyeska Investment Group
Woodline Partners
Sio Capital Management
Affinity Asset Advisors
BlackRock
BlackRock

View all funds holding Context Therapeutics